News and Trends 1 May 2015
Addex Therapeutics: When one of the leading Swiss Biotech startups relives
Biotech startups are risky. They need lot of cash to come across the very regulated clinical path and can fail rapidly when bad results show up. Addex Therapeutics, a Swiss Geneva-based Biotech…